In this episode of Everything GLP-1, Dr. Lavin speaks with Dr. Matthew French, a physician with 25 years of experience in weight loss treatment and Dr. Lavin's longtime surgical partner in bariatric surgery, to explore what sustainable success on GLP-1 therapy actually requires. Rather than framing results around maximum doses or rigid protocols, the conversation centers on individualized titration, consistent follow-up, and recognizing when a patient's hunger and cravings signal the need for adjustment.
Dr. Matthew French explains his approach of keeping patients on the lowest effective dose, while Dr. Lavin discusses the shift toward long-term microdosing for maintenance and metabolic benefit. Together, they discuss virtual versus in-office care, the risks of automatic dose escalation common in some telehealth models, and the broader health benefits patients experience beyond weight loss, including reduced inflammation and decreased cravings for alcohol and unhealthy foods.
It's a practical, experience-driven discussion for clinicians, healthcare leaders, and anyone seeking a clearer understanding of how personalized dosing and attentive follow-up drive lasting outcomes on GLP-1 therapy.
","author_name":"NINETY EIGHT STUDIOS"}